Finance Fusion Network
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Finance Fusion Network
No Result
View All Result

Intel CEO Pat Gelsinger retires, stock rises

by
December 2, 2024
in Investing
0
Intel CEO Pat Gelsinger retires, stock rises

Investing.com — Intel Corporation announced Monday that CEO Pat Gelsinger has retired from the company, stepping down from his role and the board of directors, effective December 1, 2024.

The news pushed Intel (NASDAQ:INTC) shares over 5% higher in premarket trading.

In the interim, Intel named David Zinsner, its chief financial officer, and Michelle (MJ) Johnston Holthaus, the newly appointed CEO of Intel Products, as co-CEOs.

Frank Yeary, the board’s independent chair, will serve as interim executive chair during the leadership transition. A search committee has been established to identify Gelsinger’s permanent successor.

“Pat spent his formative years at Intel and returned at a critical time in 2021,” said Yeary, adding that he helped “revitalize process manufacturing by investing in state-of-the-art semiconductor manufacturing, while working tirelessly to drive innovation throughout the company.”

Yeary emphasized the importance of prioritizing Intel’s product group, ensuring it has the resources necessary to meet customer demands while advancing manufacturing capabilities.

Holthaus will oversee the company’s Client Computing, Data Center and AI, and Network and Edge groups.

“With MJ’s permanent elevation to CEO of Intel Products along with her interim co-CEO role of Intel, we are ensuring the product group will have the resources needed to deliver for our customers,” added Yeary.

Gelsinger described leading Intel as “the honor of my lifetime,” noting the company’s resilience during a challenging year.

“I am forever grateful for the many colleagues around the world who I have worked with as part of the Intel family,” he said.

Intel faces ongoing challenges as it seeks to regain manufacturing competitiveness and strengthen investor confidence. Holthaus and Zinsner pledged to focus on process leadership and maximizing returns on Intel’s foundry investments.

This post appeared first on investing.com
Previous Post

Why the bar is high for another market outperformance in 2025

Next Post

Intel CEO Pat Gelsinger retires from struggling chipmaker

Next Post
Intel CEO Pat Gelsinger retires from struggling chipmaker

Intel CEO Pat Gelsinger retires from struggling chipmaker

  • Trending
  • Comments
  • Latest
Elon Musk connects with indie Andrew Yang on billionaire former Trump ally’s third party push

Elon Musk connects with indie Andrew Yang on billionaire former Trump ally’s third party push

July 8, 2025
Analysis-To weather Trump, emerging market investors look to the frontier

Analysis-To weather Trump, emerging market investors look to the frontier

January 27, 2025
DAVID MARCUS: Public broadcasting’s purpose has passed. It’s time to pull the plug

DAVID MARCUS: Public broadcasting’s purpose has passed. It’s time to pull the plug

February 7, 2025
Over 158 million Americans voted in 2024 as Trump reclaimed the White House

Over 158 million Americans voted in 2024 as Trump reclaimed the White House

July 7, 2025
171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

0
Harris campaign officials explain what went wrong –  and what Trump did right: report

Harris campaign officials explain what went wrong – and what Trump did right: report

0
New Republican Governors Association chair says ‘focus’ is on helping Trump get ‘off to a strong start’

New Republican Governors Association chair says ‘focus’ is on helping Trump get ‘off to a strong start’

0
NVIDIA Corporation (NASDAQ:NVDA) shares fell roughly 3%

NVIDIA Corporation (NASDAQ:NVDA) shares fell roughly 3%

0
171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

March 11, 2026
FDA launches new AI-powered system to track drug and vaccine side effects nationwide

FDA launches new AI-powered system to track drug and vaccine side effects nationwide

March 11, 2026
Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

March 11, 2026
DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

March 11, 2026

    Fill Out & Get More Relevant News

    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent News

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    March 11, 2026
    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    March 11, 2026
    Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    March 11, 2026
    DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

    DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

    March 11, 2026

    Top News

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    March 11, 2026
    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    March 11, 2026

    Latest News

    • 171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns
    • FDA launches new AI-powered system to track drug and vaccine side effects nationwide
    • Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    About Finance Fusion Network

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 Financefusionnetwork.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Latest News
    • Editor’s Pick
    • Economy

    Copyright © 2024 Financefusionnetwork.com. All Rights Reserved.